Atlas Trials

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

Clinical trial NCT00402766 · COMPLETED

Trial details

NCT number
NCT00402766
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Mesothelioma
Start date
2006-08-01
Primary completion
2014-02-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.